U.S. patent agency to weigh rival claims on gene-editing technology
Monday, December 5, 2016 - 21:41
in Physics & Chemistry
(Reuters) - The U.S. patent agency on Tuesday will hear arguments in a heated dispute over who was first to invent a revolutionary gene-editing technology known as CRISPR.